Quipt Home Medical Completes Acquisition, Delists from NASDAQ and TSX
Summary
Quipt Home Medical Corp. has completed its acquisition by affiliates of Kingswood Capital and Forager for US$3.65 per share, leading to its delisting from public exchanges.
Key Events
-
Acquisition Finalized
Quipt Home Medical Corp. was acquired by affiliates of Kingswood Capital and Forager for US$3.65 per share in cash, totaling approximately $173 million. This follows shareholder approval on March 3, 2026, and court approval on March 6, 2026.
-
Delisting Initiated
The company's shares will be delisted from NASDAQ and TSX, and it will cease to be a public reporting issuer, fundamentally altering the investment thesis for public shareholders.
-
Board and Management Changes
Several directors resigned, new directors were appointed, and key officers (CFO, CAO) resigned and were reappointed, with a new Executive Chairman named following the change of control.
Analysis
This 8-K filing confirms the definitive closing of the previously announced all-cash acquisition of Quipt Home Medical Corp. by affiliates of Kingswood Capital and Forager. The transaction, valued at approximately $173 million, provides shareholders with a cash payout of US$3.65 per share, which is near the company's 52-week high. The completion of this acquisition means Quipt will cease to be a publicly traded entity, with its shares delisted from NASDAQ and TSX, and the company terminating its public reporting obligations. This marks a fundamental change for investors, concluding their public market investment in Quipt.
At the time of this filing, QIPT was trading at $3.64 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $162.3M. The 52-week trading range was $1.35 to $3.65. This filing was assessed with neutral market sentiment and an importance score of 10 out of 10.